Drug · DIN 02490609
FLUOXETINE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 14, 2025; first marketed March 5, 2020.
- Drug Identification Number (DIN)
- 02490609
- Company (DIN owner)
- Altamed PharmaBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Fluoxetine N06AB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLUOXETINE (FLUOXETINE HYDROCHLORIDE) | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 17, 2019: NOC 22411Abbreviated New Drug Submission (ANDS) · Licensing agreeement between two companies
Other DINs named FLUOXETINE
- DIN 02286068 · Marketed
- DIN 02286076 · Marketed
- DIN 02374447 · Marketed
- DIN 02374455 · Marketed
- DIN 02192756 · Approved
- DIN 02192764 · Approved
- DIN 02231174 · Approved
- DIN 02344149 · Cancelled Post Market
- DIN 02344157 · Cancelled Post Market
- DIN 02490595 · Cancelled Post Market